Citigroup
IMMX icon

Citigroup’s Immix Biopharma IMMX Stock Holding History

Citigroup’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$446K Sell
42,864
-27,790
-39% -$315K ﹤0.01% 3821
2026
Q2 		$728K Buy
70,654
+68,190
+2,767% +$633K ﹤0.01% 3673
2026
Q1 		$22.4K Buy
2,464
+492
+25% +$3.61K ﹤0.01% 4788
2025
Q4 		$10.3K Buy
1,972
+1,937
+5,534% +$7.97K ﹤0.01% 5047
2025
Q3 		$73 Buy
+35
New +$84 ﹤0.01% 5830

Other funds holding IMMX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return
Institute for Wealth Management
Institute for Wealth Management Denver, Colorado $1.13B AUM 31.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Certuity
Certuity North Palm Beach, Florida $2.13B AUM 70.4% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Prosperity Capital Advisors
Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 15.9% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Citigroup's IMMX Position: Q3 2026 in Review

Citigroup reduced its Immix Biopharma (IMMX) stake by 39% in Q3 2026, selling an estimated $315K and leaving 42,864 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #3821.

Citigroup first reported a position in IMMX in Q3 2025 and has held it in 5 quarters since. The position peaked at $728K in Q2 2026. 38 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Citigroup held 42,864 shares of Immix Biopharma worth $446K as of Q3 2026.
  • Citigroup sold 27,790 Immix Biopharma shares in Q3 2026, an estimated $315K.
  • Immix Biopharma made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3821 holding.
  • Citigroup first reported a position in Immix Biopharma in Q3 2025 and has held it in 5 quarters since.
  • Citigroup's Immix Biopharma position peaked at $728K in Q2 2026.
  • 38 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.